Gesponsert
Atopic Dermatitis Drugs Market to Surpass US$ 28.2 Billion by 2031, Driven by Rising Disease Prevalence and Biologic Therapy Adoption
The global atopic dermatitis drugs market was valued at US$ 11.5 Billion in 2022 and is projected to reach over US$ 28.2 Billion by 2031, expanding at a compound annual growth rate (CAGR) of 8.9% from 2023 to 2031. The market is witnessing robust growth due to increasing prevalence of atopic dermatitis and continuous advancements in treatment options, particularly biologic therapies.Access key...
0 Kommentare 0 Anteile 43 Ansichten 0 Vorschau
Gesponsert
Gesponsert
Gesponsert